lobbying_activities: 823586

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
823586	749194a7-69ba-45bf-a7ca-f7ab1f582099	Q3	RUSSELL MUELLER	295292	PKD FOUNDATION	2009	third_quarter	MED	Obtained mention of PKD in Senate FY 2010 Defense Appropriations bill for research and clinical funding for PKD under Peer Reviewed Medical Research Program (Senate version of H.R. 3326), but did not obtain such funding in the House bill (H.R. 3326); Obtained sponsorship of National PKD Awareness Week Resolution for 2009 (S. Res. 241); Obtained PKD report language under FY 2010 HHS/NIH/NIDDK Appropriations House and Senate versions of H.R. 3293 for PKD forum and clinical treatment centers; Obtained funding under FY 2010 HHS Appropriations for PKD education efforts under House version of H.R. 3293. Medicare legislation: Obtain extension of immunosuppressive drug coverage under federal health programs (S. 565; H.R. 1458 and H.R. 3200).	HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE	10000		0	0	2009-10-07T16:13:42-04:00